Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis Article

Sherman, Kenneth E, Meeds, Heidi L, Rouster, Susan D et al. (2021). Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis . 8(6), 10.1093/ofid/ofab203

Open Access

cited authors

  • Sherman, Kenneth E; Meeds, Heidi L; Rouster, Susan D; Abdel-Hameed, Enass A; Hernandez, Jacqueline; Tamargo, Javier; Chen, Jun; Ehman, Richard L; Baum, Marianna

sustainable development goals

authors

publication date

  • April 21, 2021

webpage

keywords

  • FATTY LIVER-DISEASE
  • Immunology
  • Infectious Diseases
  • Life Sciences & Biomedicine
  • MACROPHAGE ACTIVATION
  • MICROBIAL TRANSLOCATION
  • Microbiology
  • Science & Technology
  • fibrosis
  • immune activation
  • liver
  • sCD163
  • steatosis

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

volume

  • 8

issue

  • 6